Research Topics
| J BryantSummaryAffiliation: University of Southampton Country: UK Publications
| Collaborators
|
Detail Information
Publications
Clinical and cost-effectiveness of cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic reviewJ Bryant
Southampton Health Technology Assessments Centre SHTAC, Wessex Institute for Health Research and Development, University of Southampton, Southampton SO16 7PX, UK
Br J Cancer 96:226-30. 2007..Further long-term research, which includes relevant outcome measures, is needed to determine whether technologies influence the development of cardiac damage without limiting the antitumour efficacy of anthracyclines...
Systematic review of the Sugarbaker procedure for pseudomyxoma peritoneiJ Bryant
Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, Southampton, UK
Br J Surg 92:153-8. 2005..The aim of this article is to assess the clinical effectiveness and costs of the Sugarbaker procedure for pseudomyxoma peritonei...
Use of cardiac markers to assess the toxic effects of anthracyclines given to children with cancer: a systematic reviewJ Bryant
Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, Mailpoint 728, Boldrewood, University of Southampton, Southampton SO16 7PX, United Kingdom
Eur J Cancer 43:1959-66. 2007..To evaluate the effectiveness of cardiac markers to quantify anthracycline-induced cardiotoxicity in children with cancer...
A systematic review of the clinical validity and clinical utility of DNA testing for hereditary haemochromatosis type 1 in at-risk populationsJ Bryant
Southampton Health Technology Assessments Centre, Mailpoint 728, Boldrewood, University of Southampton, Southampton SO167PX, UK
J Med Genet 45:513-8. 2008..To evaluate the clinical validity and clinical utility of DNA testing in people suspected of having hereditary haemochromatosis and in family members of those diagnosed with the disorder...
Payment to healthcare professionals for patient recruitment to trials: a systematic reviewJ Bryant
Wessex Institute for Health Research and Development, Boldrewood, University of Southampton, Southampton SO16 7PX
BMJ 331:1377-8. 2005
The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluationJ Picot
Southampton Health Technology Assessments Centre, Southampton, UK
Health Technol Assess 15:1-204. 2011..More recently, combination therapies have incorporated drugs such as thalidomide (Thalidomide CelgeneĀ®, Celgene) and bortezomib (VelcadeĀ®, Janssen-Cilag)...
Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic reviewJ Bryant
Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, UK
Health Technol Assess 11:iii, ix-x, 1-84. 2007..To evaluate the technologies used to reduce anthracycline-induced cardiotoxicity in children. Also to evaluate cardiac markers to quantify cardiotoxicity, and identify cost-effectiveness studies and future research priorities...
Diagnostic strategies using DNA testing for hereditary haemochromatosis in at-risk populations: a systematic review and economic evaluationJ Bryant
Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, UK
Health Technol Assess 13:iii, ix-xi, 1-126. 2009..To evaluate DNA testing for detecting hereditary haemochromatosis (HHC) in subgroups of patients suspected of having the disorder and in family members of those diagnosed with HHC...
The safety and effectiveness of different methods of earwax removal: a systematic review and economic evaluationA J Clegg
Southampton Health Technology Assessments Centre, University of Southampton, UK
Health Technol Assess 14:1-192. 2010..Current practice for earwax removal generally involves the use of a softening agent, followed by irrigation of the ear if required. However, the safety and benefits of the different methods of removal are not known for certain...
Clinical effectiveness and costs of the Sugarbaker procedure for the treatment of pseudomyxoma peritoneiJ Bryant
Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, Southampton, UK
Health Technol Assess 8:iii, 1-54. 2004..Further research involving high-quality prospective cohort studies with economic evaluations would be valuable...
A decision analysis model for diagnostic strategies using DNA testing for hereditary haemochromatosis in at risk populationsK Cooper
Southampton Health Technology Assessments Centre, Boldrewood, University of Southampton, Southampton, SO16 7PX
QJM 101:631-41. 2008..New techniques for diagnosing hereditary haemochromatosis (HHC) have become available alongside traditional tests such as liver biopsy and serum iron studies...
The clinical effectiveness and cost-effectiveness of long-term weight management schemes for adults: a systematic reviewE Loveman
Southampton Health Technology Assessments Centre, UK
Health Technol Assess 15:1-182. 2011..To assess the long-term clinical effectiveness and cost-effectiveness of multicomponent weight management schemes for adults in terms of weight loss and maintenance of weight loss...
Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia: a systematic review and economic evaluationE Loveman
Southampton Health Technology Assessments Centre SHTAC, University of Southampton, Southampton, UK
Health Technol Assess 16:iii-xiii, 1-137. 2012....
Payment to healthcare professionals for patient recruitment to trials: systematic review and qualitative studyJ Raftery
Wessex Institute for Health Research and Development, University of Southampton, UK
Health Technol Assess 12:1-128, iii. 2008..To review UK guidelines regarding the use of financial incentives for healthcare professionals to become involved in clinical trials, and to survey perceptions and current practice...
Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluationA Takeda
Southampton Health Technology Assessments Centre, Southampton, UK
Health Technol Assess 14:1-209, iii-iv. 2010....
The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluationA J Clegg
Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, UK
Health Technol Assess 9:1-132, iii-iv. 2005..A systematic review of the epidemiology of ESHF should be undertaken to assess its potential impact...
The clinical and cost-effectiveness of implantable cardioverter defibrillators: a systematic reviewJ Bryant
Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, UK
Health Technol Assess 9:1-150, iii. 2005..Further research is needed on the risk stratification of patients in whom ICDs are most likely to be clinically and cost-effective. An evaluation of shock frequency on QoL is also required...
Bortezomib for the treatment of multiple myeloma patientsC Green
Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, UK
Health Technol Assess 13:29-33. 2009....
Endocrinology trial design: adverse event reporting in randomised controlled trials of recombinant human GH in GH-deficient adultsJ Bryant
Southampton Health Technology Assessment Centre, Wessex Institute for Health Research and Development, University of Southampton, Bassett Crescent East, UK
J Endocrinol 175:545-52. 2002..Therefore those conducting endocrinology trials in the future need to pay attention to the reporting of withdrawals due to adverse events and specific adverse events...
Implantable cardioverter-defibrillators in arrhythmias: a rapid and systematic review of effectivenessJ Parkes
University of Southampton, Southampton, UK
Heart 87:438-42. 2002..To review the effectiveness of implantable cardioverter-defibrillators (ICDs) in the management of risk factors for sudden cardiac death...
Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluationJ Bryant
Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, Southampton SO16 7PX, UK
Health Technol Assess 6:1-168. 2002
Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic reviewA Clegg
Wessex Institute for Health Research and Development, University of Southampton, UK
Health Technol Assess 5:1-137. 2001..Statistically significant improvements in tests such as ADAS-cog (Alzheimer's Disease Assessment Scale cognitive subscale) may not be reflected in changes in daily life. (ABSTRACT TRUNCATED)..
Systematic review of immunomodulatory drugs for the treatment of people with multiple sclerosis: Is there good quality evidence on effectiveness and cost?J Bryant
Wessex Institute for Health Research and Development, University of Southampton, Biomedical Sciences Building Mailpoint 728, Bassett Crescent East, Southampton SO16 7PX, UK
J Neurol Neurosurg Psychiatry 70:574-9. 2001..To review the clinical effectiveness and costs of a range of disease modifying drugs in multiple sclerosis. Drugs included are azathioprine, cladribine, cyclophosphamide, intravenous immunoglobulin, methotrexate, and mitoxantrone...
Immunomodulatory drugs for multiple sclerosis: a systematic review of clinical and cost effectivenessA Clegg
Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, Biomedical Sciences Building, Bassett Crescent East, Southampton SO16 7PX, UK
Expert Opin Pharmacother 2:623-39. 2001..The inadequacies in the evidence of clinical and cost effectiveness on some immunomodulatory drugs for the treatment of people with MS necessitate further rigorous RCTs and comparative economic evaluations of different alternatives...
Non-occupational postexposure prophylaxis for HIV: a systematic reviewJ Bryant
Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, Southampton, UK
Health Technol Assess 13:iii, ix-x, 1-60. 2009..To review the evidence on the clinical effectiveness and cost-effectiveness of non-occupational postexposure prophylaxis (PEP) for HIV...
Clinical effectiveness and cost-effectiveness of growth hormone in adults in relation to impact on quality of life: a systematic review and economic evaluationJ Bryant
Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, UK
Health Technol Assess 6:1-106. 2002
Apolipoprotein E (ApoE), a novel heparin-binding protein inhibits the development of Kaposi's sarcoma-like lesions in BALB/c nu/nu miceP J Browning
Laboratory of Tumor Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892
J Exp Med 180:1949-54. 1994..ApoE-3 also inhibited the formation of neoangiogenic lesions induced in BALB/c nu/nu mice by AIDS-KS cells. These findings represent a novel and potentially less toxic therapeutic approach for the treatment of AIDS-KS...
A study of familial hypercholesterolaemia in Iceland using RFLPsR Taylor
Charing Cross Sunley Research Centre, Hammersmith, London
J Med Genet 26:494-8. 1989....
